Months 1 to 2: the silent trigger phase During the first weeks of tirzepatide treatment, the metabolic shift begins
The studied dosing starts low (about 2 mg weekly) and is increased roughly every four weeks to a target dose, with 12 mg being the highest dose in the main Phase 2 obesity trial
6 Allingbjerg and colleagues also reduced alcohol self-administration in mice after delivering the drug to the nucleus accumbens, ventral hippocampus, or lateral septum
It also upregulates growth hormone receptor expression in gastrointestinal cells, enhancing local responsiveness to GH, which plays a role in gut mucosal maintenance
73 In addition, PFT is primarily utilized to exclude chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD)
When comparing patients who initiated treatment with exenatide (n=14,076, median follow-up: 969 days), to those starting dulaglutide (n=54,787, median follow-up: 948 days) or liraglutide (n=25,562, median follow-up: 1,007 days), no differences were found in the hazard of composite treatment for diabetic macular edema (DME) and/or proliferative DR: exenatide vs